| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b0e1ef243f32a5159c89c65e39b31f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4eb6ace04c4a78cfde084acbacb4ecc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_affbdd5aa1916b26850088f5a24473ab |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-245 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate |
2000-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c4e09eefd8a6c639aae36c54e1e6717
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e34e5cba1e973cbd7e5720f190c9548c |
| publicationDate |
2000-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0061793-A2 |
| titleOfInvention |
Novel method for identifying antibacterial compounds |
| abstract |
The present invention relates to a method for identifying an antagonist or inhibitor of the expression of a gene encoding a polypeptide essential for bacterial growth or survival as well as for an antagonist or inhibitor of said polypeptide. The invention further relates to a method for improved antagonists or inhibitors. The invention also provides an antagonist or inhibitor of the activity of said polypeptide. The invention is further related to a method for producing a therapeutic agent in a composition comprising said antagonist or inhibitor. Furthermore, the invention is related to the use of the polypeptide and the antagonist or inhibitor as well as to a method to identify a surrogate marker. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1476555-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1930435-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1930435-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0220733-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03068974-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0220733-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6660507-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7056717-B2 |
| priorityDate |
1999-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |